2025 was a year of grit for BMV MedTech—we didn’t chase trends; we dug in, especially for human healthcare.
We obsessed over the details that matter:
• Our endoscope team spent 6 months refining lens clarity algorithms, boosting minimally invasive surgery visibility by 40%—a breakthrough that landed us in a top global surgical journal.
• Our CT/X-ray crew cracked the “low-dose radiation + high-res imaging” code, launching a pediatric X-ray system that’s now mandatory for China’s children’s hospitals.
• Our IVD team built a 15-minute rapid hematology analyzer—perfect for rural clinics, where it now serves 45% more patients than last year.
And we didn’t just grow better—we grew bigger:
• Our IVD gear now powers 300+ primary care clinics across Southeast Asia, where “fast, affordable testing” was once a pipe dream.
• Our endoscope-ultrasound bundles are the new standard at a major German hospital network.
• Even in the U.S., our modular monitors (FDA-compliant, naturally) just landed their first order at a top-tier hospital.
Every late night tweaking algorithms, every conversation with clinic staff, every shipment unboxed—these weren’t just “tasks.” They were the roots we planted to grow something lasting.
P.S. BMV Animal Technologies spent 2025 testing pet-specific CT and endoscopes at premium vet practices—proof that even our “side project” is built to last.